Pyrrolidine → (R)-6-{2-{Ethyl[4-(2-pyrrolidin-1-ylethyl)benzyl]amino}phenyl}-5,6,7,8-tetrahydronaphthalen-2-ol
反応式
C(CC1C=CC(C[CH2:10][CH2:11][NH:12][C:13]2[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=2[C@@H:19]2[CH2:28][CH2:27][C:26]3[CH:25]=[C:24]([O:29]C(=O)C(C)(C)C)[CH:23]=[CH:22][C:21]=3[CH2:20]2)=CC=1)(O)=O.[NH:38]1[CH2:42][CH2:41][CH2:40][CH2:39]1>>[CH2:11]([N:12]([CH2:25][C:26]1[CH:27]=[CH:28][C:19]([CH2:14][CH2:13][N:38]2[CH2:42][CH2:41][CH2:40][CH2:39]2)=[CH:20][CH:21]=1)[C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[C@@H:19]1[CH2:28][CH2:27][C:26]2[CH:25]=[C:24]([OH:29])[CH:23]=[CH:22][C:21]=2[CH2:20]1)[CH3:10]参加物
3
実験手順
Synthesized from pivalic acid (R)-6-{2-[(4-carboxymethylbenzyl)ethylamino]phenyl}-5,6,7,8-tetrahydronaphthalen-2-yl ester (28 mg) and pyrrolidine (20 mg) according to an analogous synthetic method to Example 715 and purified by LC-MS, the title compound (11 mg) was obtained.
後処理
- custompurified by LC-MS
出典と根拠
- ORDレコード
- ord-cb3f6d6e30e74398a5f0ab9d9732dc30
- 出典データセット
- uspto-grants-2009_11
- 特許番号
- US07612114B2
反応ノート
読み込み中…